A split Congress and a USPTO director looking to rebalance the system probably rule out further legislative reform, but pharma may be vulnerable to moves related to pricing issues
In upholding the first instance judgment of Mr Justice Birss last week, the Court of Appeals in London has confirmed the UK as a go-to jurisdiction for FRAND-related disputes
After years of dictating the patent narrative in the US - and reaping the rewards - BigTech now finds itself on the back foot as it loses friends in the executive and Congress. Will the courts be next?
At IPBC Australasia in Melbourne, in-house leaders discuss patent reform, doing more with less, and using IP to attract investment.
When the measure becomes law, a new Intellectual Property Tribunal within the Supreme People’s Court in Beijing will hear appeals from civil and administrative patent cases from across the country.
New edition will be effective from 1st November. As well as software-related topics, it covers issues such as unity of inventions, biological processes and changes to oral and opposition proceedings
Accuses those raising spectre of trolls of “Orwellian doublespeak” and leads call to restore balance to the system
With big ADR push behind it, office asks firms to weigh in on whether courts provide sufficient IP protection. Commissioner Naoko Munakata previewed the initiative in recent remarks at IPBC Japan.
In our latest monthly round-up of patent news from the life sciences – covering September - we report on a crucial CRISPR win for the Broad Institute, the launch of WIPO’s new pharma patent database, important judicial comings goings in the District of Delaware, and a whole lot more besides
Operating companies are now the biggest filers of new patent lawsuits, but numbers also indicate that potential heirs to Edison may have been filing many more suits than was previously thought
A state media article blasts ‘fast food-style innovation’ as abandonments data paints a bleak picture.
In keynote IPO speech, Kathleen O’Malley states that in the digital age judicial respect for IP is waning, but argues that rights holders can fight back through improved prosecution and enforcement
Violating a FRAND commitment should not give rise to an antitrust action under US law Delrahim insists as he looks for balance in debate around patent hold out and hold up.
The August edition of our monthly round-up of the life sciences stories you need to know
Fourth edition of this annual event also boasts high-profile speakers from AT&T, Cisco, Ericsson, Google, Honda, IBM, Nokia, Qualcomm, Samsung Electronics – and many more